The Division of Hematology, Antwerp University Hospital, functions as a reference center of clinical and scientific excellence for hematological patients, some of whom suffer from malignancy, require special care and/or are dependent on advanced infrastructure for diagnosis and treatment. For this, it is crucial to manage an extensive network. A close collaborative network is functioning daily with the Division of Clinical Biology, the Center for Molecular Diagnostics, the Division of Medical Genetics, the Division of Neurology, the Division of Radiotherapy, the Dialysis Section of the Division of Nephrology and the Blood Transfusion Center of Antwerp. In 2005, the Center for Cell Therapy and Regenerative Medicine (CCRG) was established at the Antwerp University Hospital. The design and function of the GMP facility of the Center for Cell Therapy and Regenerative Medicine (CCRG) meets all the requirements by the national regulatory authority, i.e. the federal agency for medicines and health products (FAMHP), to navigate R&D and preclinical phases all the way through to GMP production under a robust quality management system for clinical testing. In fact, this is the first academic GMP-certified center in Flanders that meets current EU regulations to produce ATMP